LGR5 and cancer: Our lineage-tracing experiments showed that the intrabursally injected Ad-K8-Cre not only targeted LGR5+ OSE stem cells but might also target long-lived stem cells in the FT epithelial and endometrial epithelial lineages, which are potential targets of transformation for their corresponding cancer types.